IP-10 Is Critical for Effector T Cell Trafficking and Host Survival in Toxoplasma gondii Infection  by Khan, Imtiaz A et al.
Immunity, Vol. 12, 483±494, May, 2000, Copyright ª 2000 by Cell Press
IP-10 Is Critical for Effector T Cell
Trafficking and Host Survival
in Toxoplasma gondii Infection
induced by gamma-interferon), and I-TAC (interferon-
inducible T cell a chemoattractant) and the CCR5 li-
gands MIP-1a (macrophage inflammatory protein-1a),
MIP-1b, and RANTES (Bonecchi et al., 1998; Loetscher
et al., 1998; Sallusto et al., 1998). These in vitro studies
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have been supported by studies examining chemokineHanover, New Hampshire 03755
and chemokine receptor expression in diseased tissue.² Infectious Disease Unit
Specific disease states for which Th1-type inflammatoryAIDS Research Center
responses predominate include atherosclerosis, sar-Allergy and Immunology Unit
coidosis, rheumatoid arthritis, and viral hepatitis. WeMassachusetts General Hospital
have recently reported that human atheroma expressHarvard Medical School
high levels of IP-10, Mig, and I-TAC and that virtually allBoston, Massachusetts 02114
of the T cells found in atheromatous lesions were CXCR3
positive (Mach et al., 1999). Likewise, high levels of IP-
10 were found in the broncho-alveolar lavage (BAL) fluidSummary
of patients with active pulmonary sarcoidosis and all of
the BAL T cells were CXCR3 positive (Agostini et al.,The generation of an adaptive immune response
1998). Similarly, in rheumatoid arthritis patients, T cellsagainst intracellular pathogens requires the recruit-
recovered from synovial fluid expressed higher levelsment of effector T cells to sites of infection. Here we
of CXCR3 and CCR5 than peripheral blood T cells (Qinshow that the chemokine IP-10, a specific chemoat-
et al., 1998). Recently, it has been reported that lympho-tractant for activated T cells, controls this process in
cytes infiltrating the liver of patients with chronic hepati-mice naturally infected with Toxoplasma gondii. Neu-
tis C expressed CXCR3 and CCR5 (Shields et al., 1999).tralization of IP-10 in infected mice inhibited the mas-
Interestingly, whereas the CCR5 ligands MIP-1a andsive influx of T cells into tissues and impaired antigen-
MIP-1b were confined to the vessels within the portalspecific T cell effector functions. This resulted in
tract, the CXCR3 ligands IP-10 and Mig were selectively.1000-fold increase in tissue parasite burden and a
upregulated on sinusoidal endothelium. These findingsmarked increase in mortality compared to control anti-
suggest a specific role for CXCR3 ligands, as opposedbody±treated mice. These observations suggest that
to CCR5 ligands, in the recruitment of T cells into theIP-10 may play a broader role in the localization and
hepatic parenchyma. Taken together, the above studiesfunction of effector T cells at sites of Th1 inflammation.
implicate IP-10, Mig, and I-TAC in regulating Th1 cell
trafficking into tissue where there is ongoing Th1 inflam-Introduction
mation. However, the functional importance of these
chemokines and their receptor CXCR3 in Th1-type in-The generation of an adaptive immune response in-
flammation remains to be experimentally tested, whichvolves the highly regulated trafficking of T cells, B cells,
was the goal of the present study.and dendritic cells. Dendritic cells pick up antigen in the
An established murine model of Toxoplasma gondiitissue and then migrate to regional lymph nodes, where
infection was used to study the role of chemokines inthey encounter and activate naive T and B cells (Ban-
generating organ-specific adaptive Th1-type immunity.chereau and Steinman, 1998). These activated effector
Natural infection with T. gondii results from the inges-
lymphocytes leave the lymph node and enter the blood-
tion of cysts or oocytes found in infected animal meat
stream, and must then find their way to the site where
or cat feces, respectively. Once ingested, the parasite
foreign antigen was originally encountered. Recent matures into a tachyzoite, which then invades the intesti-
studies have demonstrated that specific chemokines nal tract and disseminates to most organs. T. gondii
control the movement of naive T and B cells from the induces a strong cell-mediated response that limits par-
blood and antigen-loaded dendritic cells from the tissue asite growth in the tissue and leads to the transformation
into secondary lymphoid tissue to initiate an adaptive of the parasite from the tachyzoite into a dormant cyst,
immune response (Cyster, 1999). However, the specific resulting in an asymptomatic chronic infection (Frenkel,
chemokines that guide the migration of activated ef- 1988). This highly effective immunity is mediated by both
fector T cells from secondary lymphoid tissues into sites CD41 and CD81 T cells (Suzuki and Remington, 1988;
of infection and inflammation remain ill-defined. Gazzinelli et al., 1991; Gazzinelli et al., 1992; Khan et al.,
In vitro studies examining the expression and function 1994) and is critically dependent on the Th1 cytokine
of chemokine receptors on activated T cells have sug- IFNg (Suzuki et al., 1988; Deckert-Schluter et al., 1996).
gested that specific chemokines may control polarized Impairment of cell-mediated immunity, as seen in AIDS
CD41 T cell trafficking. Activated Th1 cells express patients, leads to a more aggressive acute infection as
CXCR3 and CCR5 and respond to the CXCR3 ligands IP- well as cyst reactivation of chronic latent disease and
10 (interferon-induced protein of 10 kDa), Mig (monokine fulminant reemergence of acute disease (Luft et al.,
1984).
We analyzed the expression of multiple chemokines³ To whom correspondence should be addressed (e-mail: luster@
helix.mgh.harvard.edu). in infected tissue and found the preferential induction
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Figure 1. Chemokine Response in T. gondii±
Infected Mice
The expression of chemokine mRNA in the
brain, spleen, and liver of C57BL/6 mice (fe-
male, 5±6 weeks old) infected orally with 15
cysts of 76K strain of Toxoplasma gondii.
RNase protection analysis was performed on
total RNA isolated from infected animals on
days 0, 3, 5, and 7 post infection. RNA was
pooled from three mice for each organ, and
each time point studied. The murine chemo-
kines studied included Ltn (lymphotactin),
C10, MIP-2 (macrophage inflammatory pro-
tein-2), MCP-3 (macrophage chemoattractant
protein-3), MIP-1b, MCP-1, IP-10, MIP-1a,
and RANTES. Expression of each chemokine
was normalized to the expression of the con-
trol ribosomal protein gene rpL32.
of IP-10 at early time points in infected tissue. Since IP- was therefore analyzed by Northern blot on RNA isolated
from the brain, liver, lung, spleen, and gut of mice in-10 is profoundly induced in cells by IFNg (Luster et al.,
1985; Luster and Ravetch, 1987) and IFNg is critical for fected with T. gondii at 3, 7, and 14 days post infection
(Figure 2). IP-10 was profoundly induced in all organshost defense against T. gondii (Suzuki et al., 1988), we
investigated the role of IP-10 in the host response to examined. In the liver, lung, and spleen, IP-10 induction
was seen by day 3, while in the brain and gut, inductionacute toxoplasma infection. To accomplish this, we have
generated neutralizing monoclonal antibodies (mAbs) to was not apparent until day 7. Expression of IP-10 peaked
by day 7 in the gut, liver, spleen, and lung but wasIP-10 that block its activation of CXCR3. Using these
mAbs, we found that IP-10 was required for survival highest in the brain on day 14. Constitutive expression
of IP-10 was seen only in the spleen and very minimallyfollowing T. gondii infection and controlled the traffick-
ing and function of activated effector T cells in tissues. in the liver. In contrast, constitutive expression of Mig
was highest in the liver and was very minimal in the
spleen. Mig expression was also induced in all organsResults
examined, although not to the same levels as IP-10.
In addition, the kinetics of Mig induction was delayedChemokine Expression in T. gondii Infection
To determine the kinetics of chemokine induction post compared to IP-10 and was not seen until day 7 post
infection. I-TAC expression was also induced followingnatural infection, we examined the expression of several
chemokines in the tissues of mice challenged orally with infection but to considerably lower levels than either IP-
10 or Mig and with a kinetic pattern more similar to Migcysts of T. gondii (Figure 1). Of the 10 chemokines exam-
ined, at early time points (days 3 and 5 post challenge) than IP-10.
there was preferential expression of IP-10 mRNA com-
pared to the other chemokines in all infected tissues Generation and Characterization of Neutralizing
Anti-IP-10 mAbsanalyzed (brain, spleen, liver, and lung) (Figure 1; data
not shown). By day 7, a significant induction of multiple To determine the functional significance of this early
and profound induction of IP-10 expression in T. gondii±chemokines was noted in the spleen, liver, and lung
(Figure 1; data not shown); however, IP-10 was still pref- infected tissues, we sought to neutralize IP-10 in vivo.
We were particularly interested in the role of IP-10 sinceerentially expressed in the brain.
We were interested in the expression pattern of the the host response to T. gondii is unaffected in mice with
a targeted disruption of the Mig gene (J. Farber, personalother known IFNg-inducible CXCR3 ligands, Mig and
I-TAC, that were not evaluated in the ribonuclease pro- communication). Neutralizing hamster anti-murine IP-
10 mAbs were generated. 1F11 and 1B9 are IP-10 mAbstection assay. The expression of IP-10, Mig, and I-TAC
IP-10 Controls Effector T Cell Trafficking
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Figure 2. Expression of IP-10, Mig, and I-TAC
in T. gondii±Infected Mice
Northern blot analysis was perfromed on total
RNA isolated from the brain, spleen, liver,
lung, and gut of C57BL/6 mice (female, 5±6
weeks old) infected orally with 15 cysts of
76K strain of Toxoplasma gondii on days 0, 3,
7, and 14 post infection. Each lane represents
RNA from a different mouse. RNA was frac-
tionated on a 1.2% agarose formaldehyde
gel, transferred to GeneScreen Plus, and se-
quentially hybridized with 32P-labeled cDNA
probes for IP-10, Mig, I-TAC, and b-actin.
of differing specificity that block the ability of IP-10 to for the highly conserved B1 gene (Burg et al., 1989) of
activate its receptor CXCR3 in chemotaxis and calcium T. gondii. Neutralization of IP-10 was associated with an
flux assays (Figure 3). These mAbs are specific for mu- z3 log increase in tissue parasite load in the tissues of
rine IP-10 and did not react with other chemokines in infected mice, compared to the tissues from control anti-
immunoassays nor inhibit the function of other chemo- body±treated mice (Figure 4B). The markedly increased
kines, including IP-10's closest known homolog murine parasite burden in anti-IP-10-treated infected mice was
Mig, with which it shares 31% amino acid identity (Figure associated with distinct histopathologic changes in
3). We cannot, however, at this time, exclude reactivity liver, spleen, and intestine (Figure 4C). Livers of infected
with murine I-TAC, which shares 26% amino acid se- anti-IP-10-treated mice had significant signs of hepato-
quence identity with murine IP-10. However, based on cellular necrosis and minimal inflammation and visible
the limited and delayed expression of I-TAC compared tachyzoites. In contrast, livers of infected control anti-
to IP-10 (Figure 2), I-TAC likely plays a less significant body±treated mice had focal areas of mononuclear cell
role in the host response to T. gondii. inflammation but minimal hepatocellular necrosis and
no visible tachyzoites. The spleens of infected anti-IP-
10-treated mice had areas of necrosis and tachyzoiteEffects of IP-10 Neutralization on the Control
proliferation, while spleens of infected control antibody±of T. gondii Infection
treated mice were devoid of necrosis and tachyzoites,T. gondii±infected C57BL/6 mice treated with either anti-
consistent with resolving T. gondii infection. The ilealIP-10 mAb 1F11 or 1B9 showed 100% mortality by day
mucosa of anti-IP-10-treated infected mice had marked15. This was in marked contrast to the mortality seen
inflammation of the lamina propria, blunting of villi, andin infected mice that received the control hamster anti-
visible parasites, while the ileal mucosa of control anti-body, which was ,30% (Figure 4A). No ill effects were
body±treated mice had minimal inflammation and noseen in uninfected mice treated with anti-IP-10 mAbs.
visible tachyzoite proliferation (data not shown). Thus,To determine whether the increased mortality in the anti-
neutralization of IP-10 in T. gondii infection resulted inIP-10-treated mice was accompanied by a greater para-
a marked increase in mortality and a profound increasesite burden, tissues from infected mice were analyzed
in tissue parasite burden, which was reflected in distincton days 10±12 post infection for the presence of parasite
DNA. The analysis was performed by PCR, using primers histopathological changes in the involved organs.
Immunity
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Figure 3. Anti-Murine IP-10 Monoclonal Anti-
bodies Inhibit IP-10-Induced Chemotaxis and
Calcium Flux of CXCR3-Transfected 300-19
B Cells
1F11 and 1B9 are two independent hamster
mAbs specific for IP-10 with different speci-
ficities that inhibit IP-10- but not Mig-induced
chemotaxis and calcium flux of murine (m)
CXCR3-transfected 300-19 B cells. (A) 1F11
and 1B9 inhibit IP-10-induced chemotaxis.
Increasing concentrations of murine IP-10
and murine Mig were preincubated with 200
mg of purified mAb 1F11, 1B9, or hamster
IgG control prior to the addition to a modified
Boyden chemotaxis chamber. The chemo-
tactic response of mCXCR3-transfected 300-
19 cells was determined by counting migrat-
ing cells per high-powered field (cells/hpf;
6 SD) in eight fields from replicate wells. Data
shown is a representative of four experi-
ments. Neither IP-10 nor Mig induced chemo-
taxis of untransfected 300-19 cells.
(B) 1F11 and 1B9 (data not shown) inhibit IP-
10-induced calcium flux. mCXCR3-trans-
fected 300-19 cells were loaded with Fura-2,
and their response to murine IP-10 (50 ng/ml)
and murine Mig (50 ng/ml) preincubated with
mAb (50 mg/ml) was monitored using a fluo-
rimeter. As a control for the cells' respon-
siveness to CXCR3 ligands, following incuba-
tion with chemokine and mAb, free chemokine
was added, which demonstrated respon-
siveness to IP-10. The partial desensitization
seen following Mig stimulation is expected
since the mAbs do not inhibit Mig-induced
responses. This is a representative experi-
ment of n 5 4. Neither IP-10 nor Mig induced
chemotaxis of untransfected 300-19 cells.
Effects of IP-10 Neutralization on T Cell Trafficking spleen, and lung of uninfected and infected mice (Fig-
ure 6). Constitutive expression of CXCR3 was presentTo determine whether IP-10 neutralization altered lym-
phocyte recruitment into infected organs, we analyzed in the spleens and very minimally in the livers and lung
of uninfected mice. Control Ab±treated infected micecells isolated from the spleens and livers of infected
mice on days 10±12 following infection. Control anti- showed a marked increase in CXCR3 mRNA levels in the
spleen, liver, and lung. In contrast, anti-IP-10 treatmentbody±treated infected mice had a substantial increase
in the total lymphoid cells in both the spleen and liver, completely blocked this increase in CXCR3 mRNA ex-
pression in the liver and lung and inhibited the increasecompared to uninfected mice (2.7-fold, p , 0.05, and
7.6-fold, p , 0.005, respectively) (Figures 5A and 5B). in the spleen by z40%. Anti-IP-10 treatment had no
effect on CXCR3 levels in uninfected animals. ThesePhenotypic analysis revealed that the increased number
of cells in both organs consisted mainly of CD31 lympho- findings, taken together with the diminished recruitment
of T cells into infected organs, suggest that IP-10 neu-cytes that were of both the CD41 and CD81 phenotype.
In the spleen, a smaller increase in NK cells was also tralization inhibited the recruitment of CXCR31 T cells
into tissues.observed. B220-positive cells did not change substan-
tially in either tissue. The influx of CD41 and CD81 lym-
phocytes into infected spleens and livers was pro-
Effects of IP-10 Neutralization on T Cellfoundly inhibited by neutralization of IP-10 (p , 0.005
Effector Functionand p , 0.05, respectively). Consistent with IP-10 mAb
To assess whether antigen-specific immune responsesinhibiting the influx and subsequent expansion of T cells
generated against T. gondii infection were affected inin infected organs, spleens (Figure 5C) and livers from
anti-IP-10- and control antibody±treated mice, mitogenanti-IP-10-treated infected mice weighed 3-fold and 1.7-
and antigen-specific proliferative responses were mea-fold less than the spleens and livers of control IgG±
sured using fractionated CD41 and CD81 splenocytestreated infected mice, respectively (p , 0.01 for both).
(Figures 7A±7D). Treatment of infected mice with anti-IP-10 mAb and control hamster IgG treatment of unin-
IP-10 or control antibody had no effect on the mitogen-fected control mice had no effect on the size or resident
induced proliferation of CD41 or CD81 T splenocytescell populations of the spleen or liver (data not shown).
(Figures 7B and 7D). However, a significant decrease inTo examine whether T. gondii infection was associ-
antigen-specific proliferation was observed for both theated with the recruitment of cells expressing the IP-
10 receptor, we examined CXCR3 expression in liver, CD41 (p 5 0.001) and CD81 (p 5 0.003) splenocytes
IP-10 Controls Effector T Cell Trafficking
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from the anti-IP-10-treated mice compared to control
Ab±treated mice (Figures 7A and 7C). Therefore, al-
though the proliferative response to mitogen was not
affected by anti-IP-10 treatment of infected mice, the
number of T. gondii±responsive CD41 and CD81 T cells
in the spleen and liver was decreased compared to con-
trol Ab±treated infected mice. In contrast, the addition
of anti-IP-10 mAb to splenocyte cultures established
from infected untreated mice had no effect on antigen-
induced proliferation (data not shown). These data sug-
gest that anti-IP-10 treatment decreased the magnitude
of the cell-mediated immune response in vivo. It is likely
that the difference between these two groups reflects
both diminished recruitment and subsequent expansion
of antigen-specific CD41 and CD81 T cells in infected
tissue.
Since cytolysis of infected cells by CD81 T cells also
plays an important role in controlling T. gondii infection
(Khan et al., 1994), we examined the ability of spleno-
cytes isolated from infected anti-IP-10 and control Ab±
treated mice to lyse T. gondii±infected macrophages in
vitro. Significantly less T. gondii±specific cytolytic activ-
ity was seen for equivalent numbers of splenocytes iso-
lated from anti-IP-10-treated infected mice compared
to control Ab±treated infected mice (p , 0.01 at 40:1
E:T ratio and p , 0.001 at 20:1 E:T ratio for anti-IP-10
compared to control Ab group). To further analyze the
differences in the number of antigen-specific cytotoxic
T cells between IP-10-treated and -untreated mice, the
precursor cytoloytic T lymphocyte (pCTL) assay was
performed on spleen cells isolated from infected animals
(Figure 7G). Splenocytes from both anti-IP-10- and con-
trol antibody±treated infected mice were cultured in a
limiting dilution assay at day 12 post T. gondii infection
and pCTL frequency of the cultures was determined.
IP-10 neutralization of T. gondii±infected mice severely
reduced the number of antigen-specific cytotoxic T
cells. While the control antibody±treated infected mice
showed pCTL frequency of 1/3.2 3 103, the anti-IP-10
mAb±treated infected mice had a pCTL frequency of
1/8.4 3 104, a 26-fold reduction. These findings are con-
sistent with the hypothesis that anti-IP-10 treatment in-
hibited the recruitment of antigen-specific effector T cells
into infected tissue. Interestingly, the production of T.
gondii±specific IgG titers was unaffected by anti-IP-10
Figure 4. IP-10 Depletion Leads to Increased Mortality and Impaired
Parasite Clearance Following T. gondii Infection in Mice
Mortality (A), tissue parasite burden (B), and histopathology (C) fol- was determined by competitive DNA PCR (Kirists et al., 2000).
lowing oral infection with the 76K strain of T. gondii in anti-IP-10- (C) Photomicrographs of representative organs from T. gondii±
and control Ab±treated C57BL/6 mice (female, 5±6 weeks old). One infected mice treated with anti-IP-10 mAbs or control IgG. Hematox-
day prior to challenge and every other day thereafter, groups of six ylin and eosin stained formalin fixed sections of liver and spleen
mice were injected i.p. with 100 mg of purified anti-IP-10 hamster from T. gondii±infected mice treated with anti-IP-10 mAbs or control
mAb (1F11 or 1B9) or control hamster IgG. IgG. Liver of anti-IP-10-treated animal shows extensive hepatocellu-
(A) Cumulative percent survival for T. gondii±infected mice treated lar necrosis with mixed inflammatory cells and visible tachyzoite
with 1F11 (n 5 24; 4 independent experiments), 1B9 (n 5 6; 1 experi- proliferation (bar 5 30 mM); inset, arrow shows intracellular tachy-
ment), and control IgG (n 5 30; 5 experiments). Similar treatment zoites (bar 5 15 mM). Liver of control antibody±treated animal shows
of uninfected mice with 1F11, 1B9, or control IgG had no effects on focal hepatocellular necrosis with mononuclear cell infiltrate but
survival. without visible tachyzoite replication. Center of a primary splenic
(B) Number of parasites per microgram of tissue DNA in the brain, follicle in anti-IP-10-treated animal shows necrosis and tachyzoite
liver, spleen, and lung of T. gondii±infected animals treated with proliferation (bar 5 50 mM); inset, arrow indicates intracellular tachy-
anti-IP-10 or control Ab. Groups of T. gondii±infected C57BL/6 mice zoites (bar 5 20 mM). The center of a primary splenic follicle of the
(female, 5±6 weeks old) were treated with anti-IP-10 mAb or control control antibody animal showing largely preserved architecture with
IgG as described above. At days 10±12 post infection, the organs minimal necrosis and no visible tachyzoites. Similar treatment of
from both anti-IP-10- and control Ab±treated mice (n 5 3 mice/ uninfected mice with 1F11, 1B9, or control IgG had no effects on
group) were isolated, and the level of parasite load in the tissues organ histopathology.
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treatment of infected mice (Figure 7F), demonstrating
that the B cell response was not grossly impaired.
Discussion
We have found that IP-10 is critical for survival following
T. gondii infection and is essential for guiding antigen-
specific CD41 and CD81 T cells into infected organs. T.
gondii evokes a strong humoral and cellular immune
response in the infected host (Decoster et al., 1988;
Innes et al., 1995). Although antibody is generated
against this pathogen, protective immunity is primarily
dependent on the cellular immune response (Johnson,
1992). Immunity to T. gondii is strictly dependent on
IFNg production by CD81 T lymphocytes as well as NK
and CD41 T cells (Suzuki et al., 1988; Deckert-Schluter
et al., 1996). IFNg has been thought to play its critical role
by activating macrophage effector functions to control
intracellular parasite replication (McCabe et al., 1984).
Our findings suggest an additional role for IFNg in host
defense through the release of IFNg-inducible chemo-
kines, such as IP-10, in recruiting effector T cells to
sites of infection. Thus, IP-10 represents a functional
link between IFNg production and T cell effector function
required for parasite containment.
It has become increasingly clear that the chemokines
orchestrate the trafficking of dendritic cells, T cells, and
B cells necessary to generate an adaptive immune re-
sponse (Cyster, 1999). Chemokines help bring together
dendritic cells that have picked up antigen in the tissue
into contact with naive T cells in secondary lymphoid
organs. For example, the trafficking of antigen-loaded
dendritic cells from the tissue into secondary lymphoid
tissue appears to be under the control of the chemokine
SLC (secondary lymphoid chemokine) and its receptor
CCR7 (Forster et al., 1999; Gunn et al., 1999). SLC and
CCR7 also play an important role in the recruitment of
Figure 5. Neutralization of IP-10 In Vivo Inhibits the Massive Influxnaive T cells into lymph nodes. The trafficking of B cells
and Expansion of T Cells in T. gondii±Infected Organsinto lymph node germinal centers is regulated by the
Immunophenotyping of splenocytes and hepatic lymphocytes fromchemokine BLC (B lymphocyte chemokine) and its re-
uninfected and T. gondii±infected mice. (A) Splenocytes and (B)ceptor CXCR5 (Forster et al., 1996). BLC and CXCR5
hepatic lymphocytes from uninfected, infected/control IgG±treated,may also play an important role in movement of helper
or infected/anti-IP-10-treated mice were quantified. Infected/control
T cells once activated out of the T cell zone and into IgG±treated mice showed a significant increase in total splenocytes
germinal centers to deliver their help to B cells (Ansel and hepatic lymphocytes compared to uninfected mice. Phenotyp-
ing revealed a significant increase in the CD31, CD41, and CD81et al., 1999). Once activated, these effector T cells then
cell populations in both the spleen and the liver. In the spleen,home back to the site of infection and inflammation. The
NK1.11 cells were also significantly increased (asterisk, p , 0.05;chemokines that control this trafficking of effector T
double asterisk, p , 0.005). No change in B2201 cells was seen incells out of lymphoid tissue and into inflamed tissue
either the spleen or liver. In the infected/anti-IP-10±treated mice,
remain ill-defined. Our study provides strong evidence no significant increase in either the total or individual lymphocyte
that IP-10 plays an important role in this process. We subsets was seen, demonstrating that neutralization of IP-10 mark-
edly decreased the number of T cells recovered from the liver andfound that neutralization of IP-10 completely inhibited
spleen compared to control IgG-treated infected mice (asterisk, p ,the influx of CD41 and CD81 cells into the spleen, liver,
0.05; double asterisk, p , 0.005). Data are presented as mean celland lung. In addition, the marked increase in CXCR3
counts (minimum 5 mice/group) 6 SD from a representative of fourexpression in the spleen, liver, and lung following infec-
independent experiments. (C) Representative spleens harvested
tion was also blocked by neutralization of IP-10. Taken from control Ab- and anti-IP-10-treated mice on day 12 following
together, these results suggest that neutralization of IP- T. gondii infection. Uninfected mice also received either control Ab
or anti-IP-10 Ab.10 blocked the influx of activated CD41 and CD81 cells,
which are known to express CXCR3.
The neutralization of IP-10 also had a dramatic effect
on the magnitude of the effector response in the tissue. to control Ab±treated infected mice. As was evident
from our data (Figure 7), this was apparent even whenAntigen-specific proliferative responses were markedly
reduced in CD41 and CD81 cells recovered from the equivalent numbers of purified CD41 and CD81 cells
were analyzed. However, the response to mitogen wasspleens of infected anti-IP-10-treated mice compared
IP-10 Controls Effector T Cell Trafficking
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Figure 6. Neutralization of IP-10 In Vivo Blocks the Recruitment of CXCR31 T Cells into T. gondii±Infected Organs
Northern blot analysis of 15 mg of total RNA isolated from the liver, spleen, and lung of uninfected, uninfected/control Ab-treated, infected/
control-Ab treated, and infected/anti-IP-10-treated mice on day 11 following oral infection with T. gondii. Each lane contains RNA from a
different mouse. Blots were sequentially hybridizied with murine CXCR3 cDNA and GAPDH or actin as a control for RNA loading. Phosphorimagor
analysis was used to quantify the CXCR3/(GAPDH or actin) mRNA signal for each sample. The inhibition of CXCR3 induction in infected
organs is likely due to the ability of the anti-IP-10 mAb to inhibit the influx of CXCR31 T cells.
unaffected, suggesting that anti-IP-10 treatment af- replication was a critical determinant of their ability to
control viral replication and was associated with differ-fected antigen-specific proliferation and did not merely
suppress proliferation non-specifically. This finding likely ential chemokine receptor expression, suggesting that
this process is under the control of chemokines (Cer-reflects the effects of anti-IP-10 treatment on the recruit-
ment and subsequent expansion of antigen-specific wenka et al., 1999). In T. gondii infection, CD81 T cells
participate in host defense by both producing IFNg andcells in the spleen. We cannot exclude the possibility
that anti-IP-10 treatment may somehow also inhibit anti- lysing infected cells (Khan et al., 1990; Hakim et al.,
1991). Anti-IP-10 treatment reduced the cytolytic activitygen specific but not mitogen induced T cell proliferation.
However, anti-IP-10 Abs had no effect on T. gondii in- found in splenocyte cultures toward T. gondii±infected
cells. This finding likely reflects the fact that there wereduced proliferation in vitro on splenocytes isolated from
infected untreated mice (data not shown). It was inter- fewer antigen-specific T cells in the spleen as IP-10
neutralization inhibited the influx of CD41 and CD81 Testing to note that the IgG antibody response was unaf-
fected by anti-IP-10 treatment. This suggests that suffi- cells into infected spleens. This hypothesis was sup-
ported the observation that anti-IP-10-treated infectedcient antigen-specific CD41 helper cells were generated
to produce a mature B cell response. Furthermore, it mice had a 26-fold reduction in the precursor CTL fre-
quency compared to control Ab±treated infected mice.also suggests that these helper T cells were able to find
their way to B cells to deliver their help. Thus, IP-10 Thus, we believe our data is most consistent with the
hypothesis that anti-IP-10 treatment inhibited the recruit-does not appear to play a critical role in helper T cell
and B cell trafficking within the secondary lymphoid ment and subsequent expansion of antigen-specific CD81
T cells in the spleen. Again, we cannot exclude the possi-tissues and germinal centers necessary to generate a
humoral response. This would suggest that CXCR31 bly that IP-10 directly augments antigen-specific cyto-
lytic function, although we have found no evidence thatand CXCR51 may represent functionally distinct sub-
populations of activated effector CD41 T cells. Since IP-10 directly effects CTL activity in vitro (A. D. L., unpub-
lished data).both of these receptors are upregulated on T cells fol-
lowing activation, perhaps IP-10/CXCR3 guide activated Our findings also dramatically demonstrate the nonre-
dundant nature of the chemokine system in vivo, whichT cells into peripheral tissue while BLC/CXCR5 guide a
different subpopulation into germinal centers. is not appreciated by standard in vitro studies of chemo-
taxis. Despite the finding that the three known IFNg-Activated CD81 cytotoxic T cells must also be re-
cruited into tissue where they play an important role in inducible CXCR3 ligands, IP-10, Mig, and I-TAC, are
expressed in infected tissue, neutralization of IP-10host defense against intracellular pathogens, including
T. gondii (Khan et al., 1994; Denkers et al., 1997). Com- blocked effector T cell recruitment into tissue and mark-
edly increased mortality. There are several possible ex-paratively little is known about the molecular mecha-
nisms controlling CTL trafficking in vivo; however, a re- planations for these dramatic results. First, it is possible
that IP-10 activates another yet unidentified receptor oncent study has suggested that chemokine receptors
expressed on CTL may be involved. In a murine influenza effector T cells that it does not share with Mig and I-TAC.
However, neutralization of IP-10 markedly inhibited themodel, the effective trafficking of CTL to sites of viral
Immunity
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Figure 7. IP-10 Depletion Following T. gondii
Infection Decreases Antigen-Specific T Cell
Proliferation and Cytotoxicity
T. gondii±infected mice were treated with
anti-IP-10 mAb or control IgG as described
above. At days 10±12 post infection, spleno-
cytes from anti-IP-10- and control antibody±
treated animals were pooled (3 mice/group)
and used for proliferation and cytotoxicity
assays.
(A±D) Proliferation. CD4 (A and B) and CD8
(C and D) T cells were purified from spleno-
cytes by positive magnetic selection (.95%
pure by FACS analysis) and stimulated with
either Con A (5 mg/ml) (B and D) or toxo-
plasma lysate antigen (TLA) (10 mg/ml) (A and
C). After a 72 hr incubation period,
3H-thymidine incorporation was measured
over 8 hr to determine the rate of DNA synthe-
sis. Data are presented as mean cpm 6 SD
and are representative of n 5 3.
(E) Cytotoxicity. Spleen cells from anti-IP-10-
and control IgG-treated mice were collected
on days 10±12 post T. gondii infection and
pooled (3 animals/group). Splenocytes were
cultured for 5 days at 1 3 106 cells/well in
the presence of 10 mg/ml of toxoplasma
lysate antigen. Live cells were separated by
Ficoll-Hypaque density centrifugation and in-
cubated with 51Cr-labeled macrophages in-
fected with PLK strain of T. gondii or unin-
fected targets at various effector:target (E:T)
ratios. Four hours after incubation, the cyto-
lytic activity was determined by radioisotope
release in the culture supernatant. Data are
representative of n 5 3, p , 0.01 for 40:1
E:T ratio and p , 0.001 for 20:1 E:T ratio,
comparing anti-IP-10 to control Ab groups.
(F) Antibody titer. Serum from toxoplasma-
infected mice treated with anti-IP-10 or con-
trol IgG was collected at day 12 post infec-
tion. Anti toxoplasma IgG titer was measured
by ELISA (3 mice/group). The titers are ex-
pressed as mean 6 SD. ND, not detected.
(G) CTL precursor frequency. Mice infected
with T. gondii were treated with anti-IP-10
mAb or control Ab (n 5 3/group). At day 12
post infection, splenocytes were isolated,
pooled, and cultured in a limiting dilution
assay as described in Experimental Proce-
dures. After one week in culture, the pCTL
frequency of the cultured cells was deter-
mined. Spleen cells from anti-IP-10-treated
infected mice had 26-fold less precursor cy-
totoxic T lymphocytes as compared to con-
trol Ab-treated infected mice (1/8.4 3 104 ver-
sus 1/3.2 3 103).
influx of CXCR31 T cells, suggesting that in this model, differential expression of these chemokins in situ. For
example, in addition to IFNg, IP-10 expression is in-IP-10 plays a dominant role in the recruitment and/or
retention of CXCR31 T cells in infected tissue. Second, duced by LPS and IFNa/b, while Mig induction is re-
stricted to IFNg. The expression of IP-10, Mig, and I-TACit is possible that the timing and pattern of chemokine
expression in tissue is a critical determinant dictating is controlled by unique promotors with different regula-
tory elements: IP-10 induction is dependent on twoa given chemokine's function in a given infectious or
inflammatory disease/model. Thus, the different roles NF-kB sites and one IRSE site (Ohmori and Hamilton,
1993), while Mig induction is dependent on a tandemof IP-10, Mig, and I-TAC in vivo may be due to the
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France). This strain is maintained by continuous oral passage ofGAS element (Wong et al., 1994). Following T. gondii
cysts. Mice were infected perorally with 10±15 cysts. For in vivoinfection, we found that IP-10 was induced at earlier
antibody experiments, groups of 5±10 mice were injected intraperi-time points compared to Mig and I-TAC. This differential
toneally every other day with 100 mg of either hamster anti-IP-10
induction may reflect the absolute dependence of Mig mAb in 200 ml of PBS or 100 mg of hamster IgG control Ab (Jackson
but not IP-10 on IFNg. In fact, we and others have seen ImmunoResearch Laboratories, West Grove, PA).
that following infection of IFNg2/2 mice with T. gondii,
IP-10 expression is reduced but not eliminated, whereas RNase Protection and Northern Analysis
RNA was prepared using Trizol (GIBCO±BRL, Grand Island, NY) orMig expression is completely eliminated (Amichay et al.,
lysis in guanidium hydrochloride followed by pelleting through a1996). Thus, perhaps the early expression of IP-10 is
CsCl2 gradient. For the RNase protection analysis, 10 mg of RNAinduced by products of T. gondii that activate the innate
from each sample was used, in duplicate. The probe set was kindly
immune system resulting in NF-kB activation. This early provided by Iain Campbell (Scrips, La Jolla, CA) (Asensio and Camp-
IP-10 expression then recruits activated Th1 cells that bell, 1997). The analysis was performed using a Riboquant RPA kit
release IFNg and amplify the local Th1 response. Alter- (PharMingen, San Diego, CA). For quantification, the autoradio-
graphs were scanned and the band density was measured usingnatively, IP-10, Mig, and I-TAC may not only be ex-
NIH image 1.62 software, and the intensity of each band was normal-pressed at different times but also in different places
ized to the intensity of the control rpL32 for each sample. For North-within a tissue leading to functional differences. We have
ern analysis, 15 mg total RNA was electrophoresed on a 1.2% aga-
recently found evidence that this can occur in situ in a rose formaldehyde gel and then capillary transferred to a
human inflammatory disease. In human atherosclerotic GeneScreen membrane (NEN Life Science Products, Boston, MA).
lesions, we have found that IP-10 is expressed in endo- Following prehybridization (50% formamide, 1% SDS, 43 SSC, 43
Denhardt's solution, 0.8% glycine, and 0.17 mg/ml denaturedthelial cells, macrophages, and smooth muscle cells,
salmon sperm DNA) at 428C, blots were hybridized at 428C in 50%while the expression of Mig and I-TAC was seen only
formamide, 10% dextran, 1% SDS, 53 SSC, 13 Denhardt's solution,in endothelial cells and macrophages and not in smooth
and 0.17 mg/ml denatured salmon sperm DNA with 1 3 106 cpm/ml
muscle cells, an important component of the vessel [a-32P]dCTP cDNA probe prepared by nick translation. The following
(Mach et al., 1999). Third, it is also possible that IP-10, fragments were used as probes: a 380 bp coding fragment of the
Mig, and I-TAC differentially activate CXCR3, resulting murine IP-10 (crg) cDNA, a 1.4 kb full-length fragment of the murine
Mig cDNA (kindly provided by J. Farber, NIH), a 829 bp fragment ofin unique biological functions in vivo. This is an intriguing
the murine I-TAC cDNA (kindly provided by G. Werner-Felmayer)hypothesis that warrants further evaluation.
(Meyer et al., 2000), and a 1 kb fragment of the CXCR3 cDNA.It was noted that at later time points following infec-
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (kindly pro-
tion, multiple chemokines were found to be highly ex- vided by M. Prystowsky) and b-actin cDNA probes were used as
pressed in infected tissues. This is in contrast to early controls for RNA loading. Signal quantitation was determined using
time points, where there was the differential expression a phosphoimager (Molecular Imager System, Bio-Rad, Hercules,
Ca), and values for each sample were normalized based on theof certain chemokines, such as IP-10. In the T. gondii
GAPDH or actin signal.model, this early expression of IP-10 plays a critical role
in establishing an effective host response to infection.
Generation and Characterization of Anti-IP-10 mAbsThe expression of multiple chemokines at later time
Anti-murine IP-10 mAbs were generated by immunizing Armenian
points likely reflects the recruitment of activated effector hamsters with recombinant E. coli±produced murine IP-10 in com-
T cells into tissues that elaborate and induce a ªsecond plete Fruend's adjuvant followed by three booster immunizations
waveº of chemokine expression. This may be relevant to of IP-10 in incomplete Freund's adjuvant. Splenocytes were fused
to P3X63 myeloma cells using a standard polyethylene glycol 1500the analysis of chemokine expression in human disease
protocol. A solid phase direct enzyme-linked immunosorbent assaytissue where typically lesional tissue is analyzed at a
(ELISA) was used to identify positive clones, which were then sub-single time point, often late in the disease. Thus, our
cloned three times by limiting dilution. mAbs were tested for their
data suggests that relevant chemokines that help estab- specificity using available purified mouse chemokines, including
lish the nature of the immune response in a tissue may Mig, MIP-1a, MIP-1b, SDF-1, KC, TCA-3, RANTES, eotaxin, MCP-1,
be those that are induced at early time points following MCP-3, and MCP-5 in a direct ELISA and immunoblot assay. 1F11
and 1B9, two mAbs specific for murine IP-10, were adapted tothe infectious or inflammatory stimulus.
serum-free medium (50% DMEM and 50% hybridoma serum-freeFinally, the broader implications of these data are that
(GIBCO) and grown in a CELLMAX cartridge (CELLCO). 1F11 andIP-10 may play an important role in the recruitment of
1B9 IgG were purified from the serum-free medium by Protein A
activated effector T cells into tissues in other Th1-type affinity chromatography (Pharmacia, Piscataway, NJ). These puri-
inflammatory diseases where it has been shown to be fied mAbs contained ,10 ng of endotoxin per milligram of IgG as
highly expressed, such as psoriasis (Gottlieb et al., determined by the Limulus amebocyte lysate assay (Associates of
Cape Cod, Woods Hole, MA). To test the ability of these mAbs to1988), sarcoidosis (Agostini et al., 1998), multiple sclero-
inhibit IP-10-induced chemotaxis, a murine CXCR3 stably trans-sis (Balashov et al., 1999; Sorensen et al., 1999), and
fected 300-19 B cell line was generated (Luster et al., 1998) andatherosclerosis (Mach et al., 1999). Further investiga-
used as a responding cell line in chemotaxis and calcium flux assays.
tions will establish whether IP-10 is functionally impor- Chemotaxis was performed in a modified Boyden chamber as de-
tant in these inflammatory conditions and whether this scribed (Luster et al., 1998), and calcium flux was measured in a
chemokine and/or its receptor will be targets for thera- PTI DeltaRam Flourimeter.
peutic intervention.
Quantitation of Parasite DNA
DNA was extracted from tissues using the Qiamp tissue kit (Qiagen,Experimental Procedures
Chatsworth, CA), and 400 ng of each sample was analyzed. Amplifi-
cation of parasite DNA was performed using primers specific forMice and Infection
Five- to six-week-old C57BL/6 were obtained from the Jackson the toxoplasma B1 gene (59-GGAACTGCATCCGTTCATGAG-39 and
59-TCTTTAAAGCTTCGTGGTC-39), a 35-fold repetitive sequenceLaboratory (Bar Harbor, ME). Mice were challenged perorally with
the 76K strain of T. gondii (kindly provided by Dr. Daniel Bout, Tours, found in all known parasite strains (Burg et al., 1989). A 134 bp
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competitive internal standard containing the same primer template Precursor Cytotoxic T Lymphocyte Frequency
To quantitate the frequency of precursor cytotoxic T lymphocytessequences as the 194 bp B1 PCR fragment was generated and used
as an internal standard for competitive PCR as described (Kirists (pCTL), spleen cells from infected anti-IP-10- and control Ab±treated
mice were cultured by limiting dilution in 96-well round bottom plateset al., 2000). Amplification of the 194 base pair segment of the B1
gene and the 134 base pair segment of the internal standard was at day 12 post infection. The cells were grown in RPMI 1640 medium
containing appropriate growth factors, including 15 units/ml of re-performed in a 50 ml reaction mix containing 1.25 units of Amplitaq
DNA polymerase, 13 buffer (Perkin Elmer), 0.2 mM each of dGTP, combinant IL-2 (R&D Chemicals, Minneapolis, MN) irradiated tachy-
zoites of PLK strain and feeder cells. Cells were diluted from 20,000dATP, dTTP, and dCTP, and 0.4 mM (each) B1 primers. For each
reaction, a known amount of DNA from the tissues was amplified to 1,250 cells/well. Control wells contained only irradiated parasites
and feeder cells. Syngenic splenocytes irradiated at 3,000 rads werewith varying amounts of the internal standard. To determine the
parasite load for the infected tissues, PCR was performed with the used as feeder cells. After one week, the cells were harvested and
incubated with 51Cr-labeled parasite-infected and -uninfected mac-same conditions using a known number of parasites. The level of
the internal control was calculated per parasite (Kirists et al., 2000). rophages. The macrophages were collected and labeled as de-
scribed above. The wells were considered to be positive for lytic
activity if total cpm released by effector cells plus target cells was
Phenotypic Analysis greater than 33 SD above control wells (mean cpm released by the
Single cell suspensions of splenocytes were prepared using stan- target cells incubated with irradiated parasites and feeder cells).
dard procedures, and hepatic lymphocytes were isolated using a The pCTL frequency was calculated according to the standard for-
modification of published methods (Watanabe et al., 1992). In brief, mula as described (Taswell, 1981).
livers were perfused with sterile PBS prior to excision to remove
blood elements. Excised livers were minced and passed through a Antibody Titer
mesh screen. The cells were washed with PBS and subjected to Antitoxoplasma antibody titer was measured by ELISA as described
density gradient centrifugation on Lympholyte-M (Accurate Chemi- (Khan et al., 1991). Purified parasites (5 3 104/ well) were placed in
cal and Scientific, Westbury, NY) to isolate the lymphocyte popula- microdilution plates, dried overnight, and blocked with 5% fetal
tion. The splenocytes and hepatic lymphocytes were suspended in bovine serum PBS. Antisera were incubated for 2 hr at 378C, and
PBS 10% FCS and counted in a hemocytometer prior to staining the plates were washed in 0.05% Tween 20 PBS. Antibody binding
with the following fluorochrome-conjugated antibodies: anti-B220 was identified with a peroxidase-labeled goat anti-mouse IgG
PE, anti-CD3 FITC, anti-CD8 FITC, and anti-NK1.1 PE (all from Phar- (Sigma Chemicals).
Mingen) and anti-CD4 Red613 (GIBCO±BRL). Two- and three-color
flow cytometry was performed on a FACscan cytometer (Becton Statistical Analysis
Dickinson, San Jose, CA), and the data was analyzed using Lysys Results of experimental studies are reported as mean 6 standard
software (Hewlett-Packard, Palo Alto, CA). deviation. Differences were analyzed using the Student's t test as
described (Neter et al., 1985). A p value , 0.05 was regarded as
significant.
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